#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trialnews2026-02-05T17:15:12+00:00February 5th, 2026|Endpoints News|
Bristol Myers draws pipeline excitement as several data readouts nearnews2026-02-05T15:50:01+00:00February 5th, 2026|Endpoints News|
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex news2026-02-05T15:22:33+00:00February 5th, 2026|Endpoints News|
Telehealth provider Hims goes after Novo’s weight loss pill with compounded versionnews2026-02-05T14:58:43+00:00February 5th, 2026|Endpoints News|
Eikon IPO analysis: Big biotech names, big valuation cutnews2026-02-05T14:32:16+00:00February 5th, 2026|Endpoints News|
Eisai gains Henlius therapy; LB Pharma snags $100M in fundingnews2026-02-05T14:21:19+00:00February 5th, 2026|Endpoints News|
Angitia gets $130M Series D for pipeline of musculoskeletal drugsnews2026-02-05T12:30:10+00:00February 5th, 2026|Endpoints News|
Flagship’s Generate:Biomedicines files for IPO, pitching AI-driven drugsnews2026-02-05T12:00:39+00:00February 5th, 2026|Endpoints News|
FTC settles insulin lawsuit with Express Scriptsnews2026-02-04T20:49:11+00:00February 4th, 2026|Endpoints News|
